These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16990018)

  • 1. An integrated microdialysis rat model for multiple pharmacokinetic/pharmacodynamic investigations of serotonergic agents.
    Bundgaard C; Jørgensen M; Mørk A
    J Pharmacol Toxicol Methods; 2007; 55(2):214-23. PubMed ID: 16990018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic/pharmacodynamic feedback modelling of the functional corticosterone response in rats after acute treatment with escitalopram.
    Bundgaard C; Larsen F; Jørgensen M; Mørk A
    Basic Clin Pharmacol Toxicol; 2007 Mar; 100(3):182-9. PubMed ID: 17309522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic model of acute autoinhibitory feedback action after administration of SSRIs in rats: application to escitalopram-induced effects on brain serotonin levels.
    Bundgaard C; Larsen F; Jørgensen M; Gabrielsson J
    Eur J Pharm Sci; 2006 Dec; 29(5):394-404. PubMed ID: 17014998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of action of antidepressants: new data from Escitalopram].
    Fabre V; Hamon M
    Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.
    Gardier AM; David DJ; Jego G; Przybylski C; Jacquot C; Durier S; Gruwez B; Douvier E; Beauverie P; Poisson N; Hen R; Bourin M
    J Neurochem; 2003 Jul; 86(1):13-24. PubMed ID: 12807420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo dialysis setup with a loop injection valve facilitates retrodialysis studies.
    Thrivikraman KV; Kinkead B; Murray KE; Owens MJ
    J Pharmacol Toxicol Methods; 2013; 68(2):217-224. PubMed ID: 23831608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine.
    Montezinho LP; Miller S; Plath N; Jensen NH; Karlsson JJ; Witten L; Mørk A
    Psychopharmacology (Berl); 2010 Oct; 212(2):131-43. PubMed ID: 20676614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple blood microdialysis in freely-moving rats for pharmacokinetic-pharmacodynamic modeling study of Shengmai injection with simultaneous determination of drug concentrations and efficacy levels in dialysate.
    Zhan S; Ding B; Ruan YE; Huang X; Liu G; Lv X; Huang X; Li M; Jiang N; Shao Q
    J Pharm Biomed Anal; 2018 May; 154():23-30. PubMed ID: 29529491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice.
    Nguyen HT; Guiard BP; Bacq A; David DJ; David I; Quesseveur G; Gautron S; Sanchez C; Gardier AM
    Br J Pharmacol; 2013 Jan; 168(1):103-16. PubMed ID: 22233336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of chronic selective serotonin reuptake inhibitor treatment on serotonin 1B receptor sensitivity and HPA axis activity.
    Jongsma ME; Bosker FJ; Cremers TI; Westerink BH; den Boer JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):738-44. PubMed ID: 15961207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic modelling of blood-brain barrier transport of escitalopram in rats.
    Bundgaard C; Jørgensen M; Larsen F
    Biopharm Drug Dispos; 2007 Oct; 28(7):349-60. PubMed ID: 17654695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain.
    Ortega JE; Gonzalez-Lira V; Horrillo I; Herrera-Marschitz M; Callado LF; Meana JJ
    Eur J Pharmacol; 2013 Jun; 709(1-3):13-9. PubMed ID: 23562616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse.
    Jacobsen JP; Plenge P; Sachs BD; Pehrson AL; Cajina M; Du Y; Roberts W; Rudder ML; Dalvi P; Robinson TJ; O'Neill SP; Khoo KS; Morillo CS; Zhang X; Caron MG
    Psychopharmacology (Berl); 2014 Dec; 231(23):4527-40. PubMed ID: 24810106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study.
    Guiard BP; Mansari ME; Murphy DL; Blier P
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):349-61. PubMed ID: 21439106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis.
    Boothman LJ; Mitchell SN; Sharp T
    Neuropharmacology; 2006 May; 50(6):726-32. PubMed ID: 16434063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin reuptake inhibition by citalopram in rat strains differing for their emotionality.
    Pollier F; Sarre S; Aguerre S; Ebinger G; Mormède P; Michotte Y; Chaouloff F
    Neuropsychopharmacology; 2000 Jan; 22(1):64-76. PubMed ID: 10633492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of increased serotonin levels on [18F]MPPF binding in rat brain: fenfluramine vs the combination of citalopram and ketanserin.
    Udo de Haes JI; Cremers TI; Bosker FJ; Postema F; Tiemersma-Wegman TD; den Boer JA
    Neuropsychopharmacology; 2005 Sep; 30(9):1624-31. PubMed ID: 15827572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.